{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "SVV",
  "name": "Savers Value Village, Inc.",
  "url": "https://frontierpicks.com/dossiers/SVV/",
  "json_url": "https://frontierpicks.com/dossiers/SVV.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a7",
    "n": 7
  },
  "current_thesis": "Busted-IPO thrift retailer's June recovery has stalled and rolled back toward its ~$9 base as the June 27 Russell-deletion passive-bid loss bites; the July 30 Q2 print is now an imminent, FX-exposed binary rather than a five-weeks-away event. The trade-down narrative is maturing, not accelerating — a name whose setup does not clear ahead of the print, not a momentum leg to chase.",
  "invalidation_trigger": "A weekly close below $8.90 breaks the May–June recovery base (also forfeiting the 200-day near $9.21) and opens a retest of the $6.91 52-week low; a Q2 comps print on July 30 under the +2.5% FY guide floor, or a cut to the FY revenue/EBITDA outlook, confirms the stall.",
  "catalyst_date": "2026-09-11",
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-08-03",
  "invalidation_fired": false,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "2026-06-27: removed from Russell 3000/2500/2000/3000E/Small Cap Value indexes — passive-bid removal and reduced liquidity; watch for residual index-driven selling into early July.",
    "Controlled company: Ares funds hold roughly 66.77% of shares outstanding after the 2026-08-12 offering and concurrent repurchase, per the offering prospectus.",
    "Deleted from the Russell 3000/2500/2000/Value indexes on 2026-06-27 — no passive index bid and a thinner liquidity base than the market cap suggests.",
    "The company sold no shares in the August 2026 secondary and receives no proceeds; the concurrent $10M repurchase was funded from cash on hand.",
    "Material non-USD exposure: Canadian net sales were $158M of $448.2M total in Q2 FY2026, plus a separate Australian segment, so reported growth carries translation effects."
  ],
  "body_markdown": "## Current Thesis\nThe July binary resolved, and it resolved upward. Q2 FY2026 (released 2026-08-06) put total comparable sales at +4.4% against +3.5% in Q1, U.S. comps at +6.6%, and the FY2026 outlook moved up on both revenue and adjusted EPS instead of down. Raised from the 15,000,000 announced 2026-08-11 — with the company buying $10M of stock from the underwriters at the same price out of cash. The block cleared and the stock closed 2026-08-14 at $10.66, above the deal price. The narrative an investor is buying here is a secondhand-retail earnings story (trade-down demand, U.S. comp acceleration, Canada margin repair) layered on a mechanical one: a 66%-owner converting stake into float at prices the market absorbs. It is working and it is well understood. What it does not have is a dated event\n\n## Bull Case\n- **Comps accelerated across the print.** Q2 FY2026 (2026-08-06): total net sales +7.4% to $448.2M, total comps +4.4% versus +3.5% in Q1 (2026-05-06); U.S. net sales +11.6% with U.S. comps +6.6%, driven by both transaction count and average basket.\n- **Canada turned.** Canada net sales +2.2% to $158M with comps +0.8% (including an approximately 70bps benefit from Easter timing), against -0.6% comps in Q1.\n- **Guidance moved up.** FY2026 adjusted EPS raised to $0.47–$0.53 from $0.45–$0.53 against a $0.48 consensus; GAAP EPS narrowed to $0.42–$0.47 from $0.41–$0.48; the FY net sales floor lifted to $1.770B from $1.760B (all 2026-08-06).\n- **Margin held at scale.** Q2 operating income $42.2M (9.4% margin), adjusted EBITDA $74.5M (16.6% margin), net income $21.6M or $0.14 per diluted share.\n- **The block was absorbed.** 20,000,000 shares at $10.25 on 2026-08-12 and a 2026-08-14 close of $10.66 says the marginal buyer showed up above the deal price rather than below it — the opposite of the June behaviour, when the 2026-06-27 Russell deletion capped the bounce near $10.\n- **Targets moved with the print.** JP Morgan maintained Neutral and raised its target to $14 (2026-08-07); Piper Sandler maintained Neutral at $11 (2026-08-07); Baird kept Outperform and raised to $13 from $12 following the quarter.\n- **Store productivity.** Four U.S. and two Canadian openings in Q2, with the North Carolina opening posting the highest opening-week sales in company history (2026-08-06 release).\n\n## Bear Case\n- **The seller is still the majority owner.** The 2026-08-12 offering prospectus states Ares funds would hold roughly 66.77% of outstanding shares after the offering and the concurrent repurchase, or 65.30% if the underwriters exercise the 3,000,000-share option in full. A holder of that size has now publicly established $10.25 as a price at which it transacts.\n- **Live supply inside the window.** The underwriters' option on 3,000,000 additional shares runs 30 days from the 2026-08-12 prospectus, to approximately 2026-09-11.\n- **Insiders sold around the print.** Form 4 trackers reported a CFO sale of $613,318.86 and a separate insider sale of $601,500 in articles dated 2026-08-10, plus 7,941 shares sold by Mark Walsh (article dated 2026-08-09).\n- **No mechanical bid.** Deletion from the Russell 3000/2500/2000/Value indexes on 2026-06-27 removed the passive buyer and thinned liquidity; that condition has not reversed.\n- **The quarter was not a clean beat.** Revenue of $448.219M came in against a $448.970M estimate and adjusted EPS of $0.14 was in line. The raise was incremental — a $10M lift to the sales floor and $0.02 on the adjusted EPS low end.\n- **Sell-side central case is modest.** The two brokers who moved on 2026-08-07 stayed Neutral, and the visible target band of $11–$14 brackets the 2026-08-14 close of $10.66 on both sides.\n- **FX translation.** Canadian sales were $158M of $448.2M total in Q2 and there is a separate Australian segment; CAD/AUD translation can make reported growth read soft even when constant-currency holds.\n\n## Setup & Price Structure\n- Last completed daily close 2026-08-14: **$10.66**. RSI(14) 59.7 — extended, not stretched. Three-month return +49.5%. Still 22.2% below the 52-week high of $13.71.\n- The ~$10 shelf that capped the June bounce has been reclaimed since the 2026-08-06 print. Above it sits $10.25, where roughly 20 million shares changed hands in a single overnight block on 2026-08-12 — a dense, recent cost shelf that now functions as the reference level for whether the deal was distribution or absorption.\n- Late-July readings had the 50-day near $9.31 and the 200-day near $9.21, with base support at $8.90 and the 52-week low at $6.91. Price now trades above both averages, which have been rising since.\n- **The narrative is maturing.** Dating it: the trade-down thesis entered the tape with the 2026-05-06 Q1 print, was confirmed by the 2026-08-06 comp acceleration, and since 2026-08-12 the dominant marginal flow has been sponsor distribution rather than fresh attention. Accelerating would require new buyers arriving faster than a 66% holder sells; the 2026-06-27 index deletion removed the largest mechanical buyer, and the two target revisions on 2026-08-07 came attached to Neutral ratings.\n- insider sales reported 2026-08-09 and 2026-08-10; no index bid since 2026-06-27; short interest reported at roughly 4.0% of float (~6.21M shares) as of July 2026; next scheduled earnings roughly three months out.\n\n## Catalyst Calendar (next 30 days)\n- **~2026-09-11 (est.)** — 30-day underwriters' option on 3,000,000 additional Ares shares expires (30 days from the 2026-08-12 prospectus). Exercise adds supply at the deal price; lapse removes the last announced tranche.\n- **2026-08-16 to 2026-09-15** — no company-scheduled event confirmed in this window: no earnings date, no guidance update, no investor day announced.\n- **~2026-11-05 (est.)** — Q3 FY2026 results (outside the 30-day window). First test of the raised FY2026 sales floor of $1.770B and the $0.47–$0.53 adjusted EPS band.\n\n## What Would Change Our Mind\nThe break here comes from supply, not demand. Visible immediately in any new 424B5 or block priced at or below $10.25. On price, a weekly close below $10.00 surrenders the June ceiling that the 2026-08-06 print converted into support, leaves the entire 20-million-share block above the market, and re-opens the late-July moving-average zone near $9.3/$9.2 and the $8.90 base beneath it. On fundamentals, a Q3 print that pulls the FY sales floor back under $1.770B, or takes adjusted EPS guidance back below $0.47, would argue the Q2 comp acceleration owed more to Easter timing and new-store contribution than to durable trade-down demand. The constructive resolution is equally observable: the ~2026-09-11 option expiry passing unexercised with price holding above $10.25 removes the announced supply and leaves the raised guide as the only thing to trade against.\n\n## Correlation Notes\n- Reads with the off-price and value-retail complex (TJX, ROST, BURL) on the consumer trade-down axis; the +6.6% U.S. comp printed 2026-08-06 is the cross-read datapoint for that group.\n- Carries an idiosyncratic FX beta through Canadian and Australian translation that peers domiciled purely in the U.S. do not — $158M of $448.2M Q2 net sales came from Canada.\n- On deal dates the stock tracks Ares's distribution schedule rather than the retail tape: coverage on 2026-08-13 attributed the week's weakness to the offering announcement, and the 2026-08-14 close of $10.66 came back above the $10.25 print.\n- Since the 2026-06-27 Russell deletion it no longer moves with small-cap index rebalance flow, which removes one source of correlated drawdown and one source of automatic support.",
  "first_seen": "2026-06-14",
  "last_analyzed": "2026-08-16T12:20:30+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}